Hedge Fund - Rhenman & Partners Asset Management
Nektar Therapeutics (NKTR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $30.25 |
| 2 | 2022 - Q4 (2022-12-31) | $1,243,000 | 0.12% | 36,666.666,666,667 | $48.40 |
| 3 | 2022 - Q3 (2022-09-30) | $2,068,000 | 0.21% | 36,666.666,666,667 | $59.49 |
| 4 | 2022 - Q2 (2022-06-30) | $2,090,000 | 0.23% | 36,666.666,666,667 | $63.09 |
| 5 | 2022 - Q1 (2022-03-31) | $3,309,000 | 0.32% | 40,925.6 | $148.00 |
| 6 | 2021 - Q4 (2021-12-31) | $13,300,000 | 0.88% | 63,333.333,333,333 | $216.94 |
| 7 | 2021 - Q3 (2021-09-30) | $17,062,000 | 1.19% | 63,333.333,333,333 | $240.45 |
| 8 | 2021 - Q2 (2021-06-30) | $16,302,000 | 1.1% | 63,333.333,333,333 | $276.75 |
| 9 | 2021 - Q1 (2021-03-31) | $26,144,000 | 1.82% | 87,146.4 | $311.24 |
| 10 | 2020 - Q4 (2020-12-31) | $22,950,000 | 1.87% | 90,000 | $258.40 |
| 11 | 2020 - Q3 (2020-09-30) | $16,590,000 | 1.47% | 66,666.666,666,667 | $314.53 |
| 12 | 2020 - Q2 (2020-06-30) | $18,296,000 | 1.97% | 52,666.666,666,667 | $312.04 |
| 13 | 2020 - Q1 (2020-03-31) | $19,189,000 | 2.68% | 71,666.666,666,667 | $309.29 |
| 14 | 2019 - Q4 (2019-12-31) | $23,744,000 | 2.6% | 73,333.333,333,333 | $289.98 |
| 15 | 2019 - Q3 (2019-09-30) | $21,858,000 | 2.74% | 80,000 | $366.74 |
| 16 | 2019 - Q2 (2019-06-30) | $25,796,000 | 2.84% | 48,333.333,333,333 | $501.44 |
| 17 | 2018 - Q4 (2018-12-31) | $16,928,000 | 1.93% | 34,333.333,333,333 | $603.64 |
| 18 | 2018 - Q3 (2018-09-30) | $18,617,000 | 1.86% | 20,359.533,333,333 | $853.54 |
| 19 | 2018 - Q2 (2018-06-30) | $30,160,000 | 3.08% | 41,176.8 | $1153.09 |
| 20 | 2018 - Q1 (2018-03-31) | $22,044,000 | 2.71% | 13,830.533,333,333 | $1288.32 |
| 21 | 2017 - Q4 (2017-12-31) | $21,111,000 | 2.85% | 23,566.866,666,667 | $591.48 |
| 22 | 2017 - Q3 (2017-09-30) | $20,789,000 | 2.65% | 57,746.266,666,667 | $312.81 |
| 23 | 2017 - Q2 (2017-06-30) | $15,542,000 | 2.23% | 53,000 | $288.99 |
| 24 | 2017 - Q1 (2017-03-31) | $11,031,000 | 1.74% | 31,333.333,333,333 | $224.79 |
| 25 | 2016 - Q4 (2016-12-31) | $5,031,000 | 0.96% | 27,333.333,333,333 | $203.32 |
| 26 | 2016 - Q3 (2016-09-30) | $6,700,200,000 | 1.06% | 26,000 | $257.48 |
| 27 | 2016 - Q2 (2016-06-30) | $6,688,000 | 1.18% | 31,333.333,333,333 | $223.52 |
| 28 | 2016 - Q1 (2016-03-31) | $7,219,000 | 1.43% | 35,000 | $192.08 |
| 29 | 2015 - Q4 (2015-12-31) | $9,790,000 | 1.48% | 38,733.333,333,333 | $205.63 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:15.0000 on 2025-06-09